Provider review
MultiMedRx review
By Derek Olsson ·
New compound offers sit beside conflicting terms
MultiMedRx now advertises compounded semaglutide and tirzepatide alongside brand-name options. Its homepage bundles an introductory four-week supply with review and shipping, but the linked terms and FAQ describe different billing and fee structures.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
MultiMedRx now provides a clearer public compound offer and advertises messaging, check-ins and lifestyle support. The central concern is the gap between its storefront and company pages: introductory bundles, Patient Care Fees, medication credits and four-week versus monthly billing are not reconciled. The published provider page still lists four jurisdictions. Before paying, obtain one written quote covering your state, exact medication, upfront total, recurring charges and cancellation deadline.
MultiMedRx isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.
Alternatives to MultiMedRx
Other providers we work with. Compare prices before you sign up anywhere.
PeterMDPartner
$149/mo new, $139/mo returning (totals don't reconcile)
RxSpan MDPartner
$249/mo flat
bmiMDPartner
$139/mo ($99 on 6-mo prepay)
Who it is for, and who it is not
A good fit if
- You want to compare brand-name access with a compounded program
- You value advertised messaging, care-team check-ins and lifestyle guidance
- You are prepared to resolve the written fee and billing differences before enrolling
Look elsewhere if
- You need a single consistent public recurring-cost explanation
- You need a nationwide service guarantee
- You need a blanket money-back guarantee after dispensing or medical discontinuation
What it actually costs
What they advertise
Semaglutide advertises a $139 introductory bundle. The current storefront shows $199 as its regular price; tirzepatide is $179 introductory and $299 regular, with four weeks of medication, evaluation and shipping advertised.
What you actually pay, month to month
The recurring total still needs a written quote. The FAQ says billing occurs every four weeks, while linked terms specify monthly care-fee re-billing of $99–$299 with a $150 medication credit. Those terms do not reconcile the current storefront bundle.
The commitment trap
The offer requires prepayment and clinical approval. The footer says prepaid totals are required; linked company pages also retain a $45 starting banner. Confirm whether care fees, medication credit, insurance costs or dose changes alter the quoted bundle.
Money you will meet later
- The FAQ distinguishes program fees from any insurance coverage for medication.
- Laboratory costs and prescription-specific future charges are not established.
Prices come from MultiMedRx's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
Compare the total cost, including fees and any minimum commitment. Here is what MultiMedRx bundles in, and what it does not.
Clinician consult
Provider evaluation is advertised in the bundle
The linked provider page describes live video plus medical-history review and names Adam Mizeracki as medical director; these are merchant statements, not an assigned visit or independent license verification.
Bloodwork / labs
Lab results are mentioned in eligibility criteria
A required panel, included allowance and testing schedule are not published in the reviewed program pages.
Follow-ups and dose changes
Care-team check-ins are advertised
Messaging and progress review are described without a fixed visit count or clinical-response deadline.
Human support
Messaging and lifestyle guidance are advertised
The storefront also offers phone contact; a specific care coordinator is not guaranteed for every patient.
Injection supplies
A complete supply kit is not specified
Confirm the exact prescribed presentation and necessary injection equipment before payment.
Shipping
The introductory bundle includes shipping
The storefront advertises expedited delivery; the FAQ also allows local-pharmacy pickup depending on insurance. Neither establishes an order-specific arrival date.
Pharmacy, labs and oversight
The pharmacy
MultiMedRx claims in-house compounding on its storefront. This is a merchant claim; the reviewed pages do not establish an independently verified dispensing facility, license or pharmacy classification for your order.
Oversight
Care-team check-ins are advertised. Messaging and progress review are described without a fixed visit count or clinical-response deadline.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
The provider page names four jurisdictions. California, Connecticut, Florida and Ohio are listed; the FAQ sends eligibility questions to intake. A Reno office address does not establish Nevada prescribing or delivery eligibility.
The honest cons
The part they would rather you skipped
The storefront and linked terms describe different costs. Introductory bundles are not reconciled with the $99–$299 Patient Care Fee, medication credit or four-week FAQ billing. Confirm which terms govern the selected program.
- Storefront offers do not reconcile with linked care-fee terms
- Four-week FAQ billing differs from monthly re-billing in the terms
- Two weeks of cancellation notice is required by the terms
- A money-back badge does not establish post-dispensing or medical-stop refund rights
Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.
Questions about MultiMedRx
Which weight-loss treatments does MultiMedRx offer?
The current storefront advertises compounded semaglutide and tirzepatide programs and retains links to Ozempic, Wegovy and Zepbound information. It claims in-house compounding, but that statement does not independently verify the dispensing facility or establish that compounded treatment is FDA-approved or interchangeable with a branded product.
What is the difference between the introductory bundle and ongoing cost?
The storefront shows semaglutide at $139 initially, regularly $199, and tirzepatide at $179 initially, regularly $299. It describes four weeks of medication plus evaluation and shipping, with prepaid totals required. Linked terms also describe care fees and a medication credit. Obtain a written total explaining which charges apply rather than adding or substituting these figures yourself.
Is the subscription billed monthly or every four weeks?
The linked FAQ specifies four-week treatment cycles billed every four weeks. The terms instead authorize monthly recurring care fees. Shipping a four-week supply does not settle the charge schedule. Confirm the exact next charge date, continuing amount and which agreement governs your chosen program.
Where can I receive care, and does insurance pay the program fee?
The provider page lists California, Connecticut, Florida and Ohio; the FAQ leaves state eligibility to intake. Its Reno address does not establish Nevada eligibility. Although the company advertises insurance acceptance, its FAQ says the program fee is separate from medication insurance coverage. Confirm both state access and drug coverage before paying.
How do I cancel, and what if the clinician declines treatment?
The terms require at least two weeks of notice and direct contact to cancel. The FAQ describes cancellation by email and promises reimbursement of the initial appointment and Patient Care Fees when treatment is declined. That promise does not establish a refund for medication already processed or a later medically necessary stop.
Does the money-back guarantee cover delivered medication?
The linked return policy describes unopened, unused items within 30 days but excludes refrigerated items and sale items. Approval and inspection are required; return shipping is paid by the customer and a restocking fee may apply. These conditions do not establish a prescription-specific refund after pharmacy processing, or a refund because treatment becomes medically unsuitable. Obtain that policy before prepaying.
Similar providers
- MyDietDocCurrent price remains unconfirmedRead review →
- MojoonTirzepatide is priced by doseRead review →
- MyFastRx$139/mo semaglutide; $199/mo tirzepatideRead review →
- Modern Age$1,500 for the initial assessmentRead review →
- myRockyExact medication pricing loads dynamicallyRead review →
- Mochi HealthAbout $139–$178 sema / $169–$278 tirz monthly, cashRead review →
Side by side: our semaglutide provider ranking · Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Provider offers and terms are based on MultiMedRx's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on MultiMedRx's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.